Sun Pharma acquires US-based Pharmalucence

Tags: Companies
Drug major Sun Pharmaceutical Industries has acquired US-based Pharmalucence Inc for an undisclosed amount.

Pharmalucence, which has sterile injectable capacity in the US, has been acquired by one of the subsidiaries of Sun Pharma, the Mumbai-based firm said in a statement today.

The company, however, did not disclose the financial details of the deal.

Earlier this year, Sun Pharma had acquired Ranbaxy Laboratories in an all-stock transaction with a total equity value of $3.2 billion along with debt of $800 million, taking the overall deal value to $4 billion.

Sun Pharma shares were trading at Rs 748.30, up 1.30 per cent from its previous close.


  • The govt should build on the feel good season to bolster its economic agenda

    There are two pieces of good news to ring in the festive season beginning this Dusshera.


Stay informed on our latest news!


Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs


Sachin Shridhar

Reordering the world order on cheap money

When you produce something, just about anything, capital is ...

Rajgopal Nidamboor

Of archetypes, not stereotypes

It is not that devising technologies, or progress, is a ...

Dharmendra Khandal

Use technology wisely to save earth's treasures

Wildlife biologists are certainly getting inspired by our armed forces’ ...


William D. Green

Chairman & CEO, Accenture